Medication

In the Phase 1b Heart-2 trial, a single intravenous infusion of VERVE-102 produced dose-dependent lowering of PCSK9 and…

Flowers produce oils mainly to attract pollinators such as bees and butterflies. As a result, flower oils are…

Open this photo in gallery: Ozempic pens on a production line at the Danish drugmaker Novo Nordisk. Generic…

Two generic versions of Ozempic and Wegovy are set to start arriving in Canadian pharmacies this week, which…

The Healing the Collective Faire brought a wide range of holistic wellness resources to Great Falls over the…

Aled Thomas said he would not be shamed into silence by those abusing him Mounjaro campaigner Aled Thomas(Image:…

Researchers found that many commonly prescribed drugs, not just antibiotics, were linked to long-lasting microbial changes that could…

Ashwagandha remains one of the most recognized Indian herbal ingredients globally, with the Indian Ashwagandha supplements market valued…

Experts claim that consistent sessions can help treat an array of respiratory issues like snoring, asthma, wheezing, chronic…

A wave of prescription weight-loss medications has swept across Australia, reshaping how doctors treat obesity and forcing regulators…

The Food and Drug Administration (FDA) approved Hepcludex on Friday for the treatment of chronic hepatitis D, ending…

Patna: Residents across the city faced inconvenience on Wednesday as medicine shops remained closed during a nationwide strike…

A single dose of Lilly’s PCSK9 base editor, VERVE-102, reduced PCSK9 by up to 88% and LDL-C by up to 62%, with durable effects supporting its potential as a one-time treatment for hypercholesterolemia